Announces that the contract development and manufacturing organization engaged by its funding and commercialization partner, Sequel Pharma, LLC, has modernized production methods for the active ingredient of Kinlytic® urokinase, a biologic for dissolving blood clots. Microbix Biosystems Inc. shares T.MBX are trading up $0.02 at $0.25.
Stocks in play: Microbix Biosystems Inc.
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here